Aug 2026· Journal of Biological Chemistry· Vol 302· 0 citations· 38 references
Medicine
TL;DR
It is demonstrated that coordinated regulation of both cytosolic and mitochondrial translation during totipotent-like reprogramming is offered, offering a new perspective for understanding cell fate determination.
Abstract
Embryonic stem cells (ESCs) are characterized by their dual capacity for self-renewal and differentiation into all cell types of the embryonic lineage. A subpopulation known as 2-cell-like cells (2CLCs), which recapitulate key molecular and metabolic features of totipotent 2-cell blastomeres, has been identified within cultured mouse ESC populations. While transcriptional regulation, epigenetic modifications, and chromatin reorganization are known to be critical for the reprogramming of pluripotent ESCs into a totipotent-like state, the role of translational control in this process remains poorly understood. Using an inducible 2CLC model, we performed transcriptome-wide profiling of mRNA translation and found that global translation efficiency dynamically decreases during the early phase of totipotent-like reprogramming, correlating with reduced TORC1 signaling and translation initiation. In the later phase, although overall mitochondrial mass declines, mitochondrial translation is selectively upregulated and exhibits high translational efficiency. Importantly, pharmacological inhibition of mitochondrial translation suppressed the expression of canonical 2-cell transcripts and impaired the transition from ESCs to 2CLCs. Together, these results demonstrate the coordinated regulation of both cytosolic and mitochondrial translation during totipotent-like reprogramming, offering a new perspective for understanding cell fate determination.
These findings establish IRAK4 as a regulator that constrains cellular plasticity potentially by coordinating chromatin accessibility and cell cycle dynamics, which may facilitate the establishment of multi-lineage states.
Chuanshu Huang, Xiao-Yun Han, Tao Wang et al.· EMBO Reports· 0 citations
This review discusses how organoids and OoC-based platforms are being leveraged to study and enhance cell fate reprogramming, repair, and regeneration across multiple tissues and outlines current limitations, including scalability, standardization, and biomaterial constraints.
Hrithiha Sriramulu, Hyunsung Woo, Anavi Kaul et al.· Current Opinion in Genetics...· 1 citation
This study has established a highly efficient in vitro model for totipotency induction and highlighted molecular barriers shaping cell fate decisions, providing a platform to dissect the mechanisms governing the pluripotency-to-totipotency transition.
Siling Hu, Ping-Hui Zhu, He Liu et al.· bioRxiv· 0 citations
It is predicted that centriole elimination combined with totipotency factors will yield stable, self-renewing totipotent cells, distinct from transient 8C-like cells.
The criteria for direct lineage reprogramming, atypical pluripotent reprogramming and noncanonical pluripotent reprogramming are delineated, and novel approaches like bacterial ribosome‐mediated cell fate conversion are explored like bacterial ribosome‐mediated cell fate conversion.
Anamika Datta, Kunimasa Ohta· Development, Growth and Diff...· 0 citations
These findings uncover miRNA isoform diversity as a programmable regulatory layer in immune cell specification and establish RNA-driven reprogramming as a non-viral strategy for cancer immunotherapy.
Nejc Arh, I. Kurochkin, Beatriz Lourenço Vaz et al.· Cell Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.